Drug intelligence / Profile preview

Qing Re He Ji

Development stage: Phase 2
Modality: Small Molecules
Administration: Oral

Overview

Qing Re He Ji is a traditional Chinese medicine (TCM) herbal formulation widely used for the treatment of acute upper respiratory tract infections (AURI). It is designed to "clear heat," eliminate pathogenic factors, and strengthen healthy qi according to TCM theory. Clinical applications have demonstrated its effectiveness in alleviating symptoms such as fever, sore throat, cough, and other manifestations associated with AURI. The formula typically contains a combination of herbs with anti-inflammatory and antiviral properties that act synergistically to reduce inflammation and support immune function[4]. Its mechanism of action involves modulation of inflammatory pathways; however, specific molecular targets are not well characterized in Western pharmacological terms.

Brand names: Qing Re He Ji
Other names: QRHJ清热合剂

Beyond the preview

Go deeper on Qing Re He Ji.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qing Re He Ji.

Explore the full profile